HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed May 22, 2020
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2020-05-20$26.67/sh−4,212$112,334→ 312,456 total
4 · Theravance Biopharma, Inc. · Filed May 22, 2020
Ordinary Shares